We are live on ! Find out more
VIM

Vinva Investment Management Portfolio holdings

AUM $8.07B
1-Year Est. Return 29.46%
This Fund
S&P 500
This Quarter Est. Return
+13.57%
1 Year Est. Return
+29.46%
3 Year Est. Return
+116.68%
5 Year Est. Return
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$397M
Cap. Flow
+$247M
Cap. Flow %
16.8%
Top 10 Hldgs %
29.27%
Holding
417
New
62
Increased
255
Reduced
73
Closed
27

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$17.2M
2
AAPL icon
Apple
AAPL
+$14.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$12.9M
4
MSFT icon
Microsoft
MSFT
+$10.9M
5
NVDA icon
NVIDIA
NVDA
+$7.67M

Sector Composition

Rank Sector Weight
1 Technology 31.76%
2 Financials 14.39%
3 Healthcare 12.74%
4 Consumer Discretionary 12.55%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
101
Vertex Pharmaceuticals
VRTX
$134B
$3.68M 0.25%
9,003
+1,006
+13% +$372K
SBUX icon
102
Starbucks
SBUX
$121B
$3.64M 0.25%
37,909
+19,571
+107% +$1.9M
MDLZ icon
103
Mondelez International
MDLZ
$78.5B
$3.63M 0.25%
50,194
+10,461
+26% +$717K
TJX icon
104
TJX Companies
TJX
$173B
$3.61M 0.25%
38,723
+7,767
+25% +$697K
COR icon
105
Cencora
COR
$62.8B
$3.54M 0.24%
17,374
+8,627
+99% +$1.68M
SCHW
106
Charles Schwab
SCHW
$187B
$3.52M 0.24%
50,614
+7,542
+18% +$436K
UNP icon
107
Union Pacific
UNP
$174B
$3.51M 0.24%
14,278
+1,385
+11% +$305K
CVS icon
108
CVS Health
CVS
$119B
$3.51M 0.24%
44,389
+6,003
+16% +$427K
DIS icon
109
Walt Disney
DIS
$178B
$3.47M 0.24%
38,395
+14,123
+58% +$1.25M
AMT icon
110
American Tower
AMT
$79.5B
$3.47M 0.24%
15,981
+2,265
+17% +$428K
KLAC icon
111
KLA
KLAC
$259B
$3.37M 0.23%
57,510
+12,460
+28% +$649K
MS icon
112
Morgan Stanley
MS
$339B
$3.33M 0.23%
35,560
+7,839
+28% +$627K
ROST icon
113
Ross Stores
ROST
$81.5B
$3.32M 0.23%
23,999
+2,336
+11% +$291K
REGN icon
114
Regeneron Pharmaceuticals
REGN
$83.3B
$3.26M 0.22%
3,698
+530
+17% +$436K
WIX icon
115
WIX.com
WIX
$2.76B
$3.24M 0.22%
25,116
+12,537
+100% +$1.21M
MPC icon
116
Marathon Petroleum
MPC
$93.6B
$3.22M 0.22%
21,937
+3,729
+20% +$554K
MRSH
117
Marsh
MRSH
$91.7B
$3.19M 0.22%
16,922
+2,526
+18% +$488K
ADI icon
118
Analog Devices
ADI
$188B
$3.19M 0.22%
15,943
+6,514
+69% +$1.16M
RCL icon
119
Royal Caribbean
RCL
$81.3B
$3.15M 0.21%
24,228
-36,154
-60% -$3.69M
PANW icon
120
Palo Alto Networks
PANW
$314B
$3.13M 0.21%
21,198
+3,342
+19% +$447K
VTRS icon
121
Viatris
VTRS
$18.6B
$3.09M 0.21%
284,964
+173,644
+156% +$1.66M
AOS icon
122
A.O. Smith
AOS
$8.63B
$3.07M 0.21%
+37,317
New +$2.75M
CI icon
123
Cigna
CI
$71.7B
$3.06M 0.21%
10,217
+1,498
+17% +$438K
ZTS icon
124
Zoetis
ZTS
$31B
$3.02M 0.21%
15,331
+1,966
+15% +$348K
CB icon
125
Chubb
CB
$134B
$3M 0.2%
13,345
+1,153
+9% +$252K

Similar funds

Vinva Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Vinva Investment Management held 417 positions worth $1.47B, up 37% from $1.07B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Vinva Investment Management deployed $247M of net new capital in Q4 2023, opening 62 new positions and adding to 255 existing holdings. Its largest new stake was UnitedHealth: 32,283 shares worth $16.9M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Idexx Laboratories, an estimated $4.19M trimmed.

  • Vinva Investment Management's largest Q4 2023 buy was UnitedHealth: 32,283 shares worth $16.9M.
  • Vinva Investment Management added most to Apple in Q4 2023, an estimated $14.3M increase.
  • Vinva Investment Management's biggest Q4 2023 reduction was Idexx Laboratories, cutting an estimated $4.19M.
  • Vinva Investment Management fully exited Clorox in Q4 2023, selling an estimated $3.43M.
  • Vinva Investment Management's ten largest holdings make up 29% of its $1.47B portfolio in Q4 2023.
  • Vinva Investment Management opened 62 new positions and closed 27 in Q4 2023.
  • Vinva Investment Management's portfolio value rose 37% quarter-over-quarter to $1.47B.

Based on Vinva Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.